CompletedNCT05939713
Cera™ VSD Occluder Post Market Clinical Follow-up
Studying Rare congenital anomaly of ventricular septum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cardiac Children's Foundation Taiwan
- Principal Investigator
- Jou-Kou WangNational Taiwan University Hospital
- Intervention
- Cera™ VSD occluder implantation(device)
- Enrollment
- 152 enrolled
- Eligibility
- 3 years · All sexes
- Timeline
- 2023 – 2025
Study locations (8)
- Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
- Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan
- Taichung Veterans General Hospital, Taichung, Taiwan
- National Cheng Kung University Hospital, Tainan, Taiwan
- National Taiwan University Hospital, Taipei, Taiwan
- Taipei Mackay Memorial Hospital, Taipei, Taiwan
- Taipei Veterans General Hospital, Taipei, Taiwan
- Linkou Chang-Gung Memorial Hospita, Taoyuan District, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05939713 on ClinicalTrials.govOther trials for Rare congenital anomaly of ventricular septum
Additional recruiting or active studies for the same condition.
See all trials for Rare congenital anomaly of ventricular septum →